Document Detail


The effects of alginate encapsulation on NIT-1 insulinoma cells: viability, growth and insulin secretion.
MedLine Citation:
PMID:  20023235     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Transplantation of microencapsulated insulin-secreting cells is proposed as a promising therapy for the treatment of type I diabetes mellitus. In recent years, important advances have been made in the field of immunoisolation and many studies have shown that alginate provides some major advantages for encapsulation over other systems. Since it is known that the extracellular matrix influences the behaviour of encapsulated cells, the aim of the present work has been to study the consequences of encapsulation on some cell functions. For this purpose, cell growth and dynamics of insulin release of NIT-1 cells entrapped in alginate capsules compared with those exhibited by free NIT-1 cells were investigated by means of growth curves, assays, Trypan blue staining and ELISA test. All investigations performed allowed us to conclude that alginate-entrapped NIT-1 cells maintain their growth features and secretory functions although with some important differences. In particular, alginate encapsulation affects the cellular growth profile and causes the lost of time dependence of insulin secretion profile.
Authors:
Alessia Bertolotti; Massimiliano Borgogna; Angelica Facoetti; Eleonora Marsich; Rosanna Nano
Related Documents :
10215165 - Transforming growth factor-beta, but not ciliary neurotrophic factor, inhibits dna synt...
3378215 - Characterization of a low-molecular-weight growth inhibitor formed by density-inhibited...
9242465 - Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects i...
17761895 - Inactivation of the igf-i receptor gene in primary sertoli cells highlights the autocri...
555685 - Megakaryocyte colony culture using a liver cell conditioned medium.
12646585 - Control of cell polarity in fission yeast by association of orb6p kinase with the highl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  In vivo (Athens, Greece)     Volume:  23     ISSN:  0258-851X     ISO Abbreviation:  In Vivo     Publication Date:    2009 Nov-Dec
Date Detail:
Created Date:  2009-12-21     Completed Date:  2010-03-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8806809     Medline TA:  In Vivo     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  929-35     Citation Subset:  IM    
Affiliation:
Department of Nuclear, Universit? degli Studi di Pavia, Pavia, Italy. BertolottiAlessia@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alginates / chemistry,  pharmacology*
Animals
Biocompatible Materials / chemistry,  pharmacology*
Cell Line, Tumor
Cell Survival / drug effects
Cell Transplantation / methods*
Drug Carriers / chemistry,  pharmacology*
Drug Compounding
Fungal Proteins
Glucuronic Acid / chemistry,  pharmacology
Hexuronic Acids / chemistry,  pharmacology
Insulin / secretion
Insulinoma / drug therapy*,  pathology,  secretion
Islets of Langerhans / drug effects,  pathology,  secretion
Mice
Trans-Activators
Chemical
Reg. No./Substance:
0/Alginates; 0/Biocompatible Materials; 0/Drug Carriers; 0/Fungal Proteins; 0/Hexuronic Acids; 0/Trans-Activators; 11061-68-0/Insulin; 144590-62-5/NIT-4 protein, Neurospora crassa; 576-37-4/Glucuronic Acid; 9005-32-7/alginic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Frequency of Glassy Cells in Barrett's Mucosa: A Study in Baboons.
Next Document:  Imbalance of tumor suppression genes expression following rat tongue carcinogenesis induced by 4-nit...